Equity
Total Liabilities & Equity
Pfizer Total Liabilities & Equity decreased by 0.3% to $208.16B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $213.40B to $208.16B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 6.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
Detailed definition
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
Peer comparison
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
Metric ID:
total_liabilities_and_equityHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.92B | $179.19B | $181.48B | $183.84B | $195.29B | $195.35B | $197.21B | $195.62B | $220.17B | $215.02B | $226.50B | $221.10B | $216.19B | $219.48B | $213.40B | $208.03B | $206.10B | $208.73B | $208.16B |
| QoQ Change | — | +5.5% | +1.3% | +1.3% | +6.2% | +0.0% | +0.9% | -0.8% | +12.6% | -2.3% | +5.3% | -2.4% | -2.2% | +1.5% | -2.8% | -2.5% | -0.9% | +1.3% | -0.3% |
| YoY Change | — | — | — | — | +14.9% | +9.0% | +8.7% | +6.4% | +12.7% | +10.1% | +14.9% | +13.0% | -1.8% | +2.1% | -5.8% | -5.9% | -4.7% | -4.9% | -2.5% |
Range$169.92B – $226.50B
CAGR+4.6%
Avg YoY Growth+4.4%
Median YoY Growth+6.4%
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Pfizer's total liabilities & equity?
- Pfizer (PFE) reported total liabilities & equity of $208.16B in Q4 2025.
- How has Pfizer's total liabilities & equity changed year-over-year?
- Pfizer's total liabilities & equity decreased by 2.5% year-over-year, from $213.40B to $208.16B.
- What is the long-term trend for Pfizer's total liabilities & equity?
- Over 5 years (2020 to 2025), Pfizer's total liabilities & equity has grown at a 6.2% compound annual growth rate (CAGR), from $154.23B to $208.16B.
- What does total liabilities & equity mean?
- The total amount of money a company owes to others plus the value owned by its shareholders.